Oral therapy for gonorrhoea abandoned

A global surge in antibiotic-resistant gonorrhoea has prompted experts to abandon a key oral first-line treatment, amid fears the bacteria could become untreatable.

The US Centers for Disease Control and Prevention said last Friday doctors should give up on the oral cephalosporin cefixime, which it had previously recommended as first-line therapy, and move straight to combination injectable ceftriaxone plus azithromycin or doxycycline.

It blamed the changes on growing global resistance to cefixime, citing